How Seasonal Depression Works: Causes and Treatments

Seasonal depression stems from light-driven shifts in your body clock, serotonin, and melatonin. Learn what causes it and which treatments actually help.

Seasonal depression, formally called seasonal affective disorder (SAD), is driven by the way shortened daylight hours in winter disrupt your brain’s internal clock, serotonin regulation, and melatonin timing. A recent meta-analysis pooling data from over 32,000 participants found a pooled prevalence of about 5%, with higher rates at higher latitudes. But the story is more layered than “less sunlight equals sadness,” and the treatments available go well beyond sitting in front of a bright light, though that works too.

What Happens in the Brain When Days Get Shorter

Your brain keeps time using a cluster of cells in the hypothalamus called the suprachiasmatic nucleus, or SCN. Specialized cells in your retina that contain a light-sensitive pigment called melanopsin send signals directly to this clock region. From there, the SCN synchronizes your sleep-wake cycle, appetite, body temperature, and hormone release by projecting to areas that control waking, sleep, mood, and the pineal gland, which produces melatonin. When winter shrinks the window of available light, these signals shift, and the downstream effects cascade through mood-regulating circuits.

The leading explanation for how this cascade produces depression is the phase shift hypothesis. In most people with winter SAD, the body’s internal clock drifts later relative to the sleep-wake cycle. Melatonin onset shifts, and the normal timing relationship between melatonin release and sleep gets thrown off. In a study testing this directly, researchers gave SAD patients low-dose melatonin at different times of day to either push or pull their internal clocks back into alignment. Symptoms improved as the mismatch between melatonin onset and sleep timing was corrected. In healthy people, that interval sits at about six hours, and the same interval was associated with optimal mood in the patients.

The Serotonin Problem

Circadian disruption does not work alone. Serotonin, the neurotransmitter most associated with mood stability, plays a central and somewhat surprising role. People with SAD and healthy controls have similar levels of the serotonin transporter (the protein that clears serotonin from synapses) during summer. But during winter, people with SAD show higher transporter levels than controls. More transporter activity means serotonin gets pulled out of the synapse faster, leaving less available to do its mood-regulating work.

What makes this finding especially interesting is the comparison with people who stay well through winter. Individuals resilient to seasonal mood changes actually do the opposite: they downregulate their serotonin transporter in winter, keeping more serotonin in play. The difference is not that SAD patients are abnormal and everyone else is normal. Everyone’s serotonin system shifts with the seasons. The difference is the direction: resilient brains compensate for less light by holding onto serotonin, while vulnerable brains lose it.

This serotonin connection also helps explain one of the hallmark symptoms of winter SAD: intense carbohydrate cravings. Eating carbohydrates triggers a chain of events that ultimately increases serotonin production in the brain. The cravings may be, in a sense, the brain trying to self-medicate a serotonin shortfall. This is why weight gain is so commonly reported alongside the fatigue and low mood of SAD.

Genetic Susceptibility

Not everyone at the same latitude develops seasonal depression, and genetics help explain why. Multiple genes involved in the circadian clock have been linked to heightened seasonality risk, with the effects often differing by sex. In one study, certain combinations of clock gene variants were associated with a roughly sevenfold increase in seasonality risk in men and a ninefold increase in women. These are not single genes acting in isolation; the risk comes from the way multiple variants interact.

Research in a Korean population identified a variant in the CLOCK gene that was nearly twice as common among people with seasonal mood changes compared to those without. Beyond the CLOCK gene, variants in related genes influenced seasonal patterns in appetite and body weight rather than mood directly, and the combination of CLOCK and ARNTL variants together increased susceptibility more than either alone. This fits the clinical picture: different people get different clusters of symptoms, some dominated by mood changes, others by sleep and appetite disruption, likely reflecting which parts of their circadian machinery are most affected.

Why Iceland Complicates the Latitude Story

You would expect SAD to get steadily more common the farther north you go. The data partly support this: in North America, prevalence correlates with latitude. But the relationship is not as clean as a simple “more darkness, more depression” formula would predict. Across all global studies, the overall correlation between latitude and SAD has historically been inconsistent, with rates in North America running about twice as high as Europe even at comparable latitudes.

Iceland is the most striking outlier. Despite sitting between 63° and 66° north, where winter days can be just a few hours of twilight, the estimated prevalence of SAD there is significantly lower than on the east coast of the United States, which sits much farther south. The Icelandic population has been genetically isolated for roughly a thousand years, and researchers have proposed that individuals predisposed to severe winter depression may have been at a reproductive disadvantage over centuries, leading to a kind of population-level selection toward greater tolerance of winter darkness. A more recent meta-analysis still found a positive association between latitude and SAD prevalence globally, but the exceptions like Iceland suggest genetic adaptation and cultural factors matter alongside geography.

Light Therapy and How to Get It Right

Light therapy remains the first-line treatment most clinicians recommend for SAD, and the evidence behind it is strong. A meta-analysis across eight studies found a large effect on symptom reduction, and dawn simulation devices (which gradually brighten before you wake up) also showed a meaningful benefit. A head-to-head trial comparing light therapy with fluoxetine (an SSRI antidepressant) found the two were equally effective, with clinical response rates of about 67% in both groups and similar remission rates. Light therapy produced faster improvement in the first week and fewer side effects.

Dawn simulation is an alternative worth knowing about. These devices sit on your bedside table and gradually increase light intensity over 30 to 90 minutes before your alarm, mimicking a natural sunrise. Some studies have found dawn simulation comparable to standard bright light boxes, with one reporting nearly identical symptom reductions of around 42–44%. Another controlled study actually found dawn simulation outperformed bright light therapy in both remission and response rates. That said, at least one trial found the light box produced greater improvement than dawn simulation. The evidence overall suggests the two approaches are in a similar range, and the best choice often comes down to what you will actually use consistently. Dawn simulators have the advantage of working while you sleep, requiring no dedicated sitting time.

A practical concern with light boxes is quality. A study examining commercially available devices found that the physical properties of the light they emitted varied enormously. Only seven larger light boxes met all three clinical criteria for effective treatment. Some devices marketed as delivering 10,000 lux only reached that intensity at distances too close to be practical, or produced uneven, glare-heavy light. Light therapy devices are generally not regulated as medical devices, so “10,000 lux” on the box does not guarantee a clinically useful light field in practice. When shopping for one, look for a large surface area, even illumination, and the ability to sit at a comfortable distance while still receiving adequate intensity.

Cognitive-Behavioral Therapy Has a Lasting Edge

Light therapy works well while you are using it, but the recurrence rates once you stop are high. Cognitive-behavioral therapy adapted for SAD (CBT-SAD) takes a different approach: instead of changing the light input, it targets the behavioral withdrawal and negative thought patterns that feed the winter depressive cycle. In a direct comparison, light therapy and CBT-SAD performed similarly during the first treatment winter. But by the second winter of follow-up, about 46% of the light therapy group had relapsed compared to about 27% of the CBT-SAD group. The CBT group also had less severe symptoms and higher remission rates.

Pilot data from the same research group found even more dramatic differences in recurrence prevention. In one preliminary study, the light-therapy-only group had a recurrence rate of about 37%, while the CBT group’s rate was 7%. CBT-SAD teaches skills you carry from one winter to the next. Light therapy requires re-engaging with the device every season. For someone looking for long-term prevention rather than annual acute treatment, CBT-SAD has the strongest case, though combining the two is reasonable and commonly done.

Medication for Prevention

For people with a pattern of recurring winter depression who want a pharmacological approach, bupropion extended-release (XL) is the most studied preventive option. A Cochrane review of three randomized trials involving 1,100 participants found that bupropion XL reduced the risk of a new depressive episode by about 44% compared to placebo. The typical strategy is to start the medication in early autumn, before symptoms would normally begin, and continue through winter.

The trade-off is side effects. Bupropion XL carried higher rates of headaches, insomnia, and nausea compared to placebo. How worthwhile the trade-off is depends partly on how reliably your depression recurs: for someone who gets hit hard every winter without fail, treating roughly five to eight people to prevent one episode is a reasonable number. For someone with a less predictable pattern, the math looks different. No other antidepressants have been adequately studied specifically for SAD prevention, and no head-to-head trials have compared bupropion with light therapy or CBT for this purpose.

The Vitamin D Question

Vitamin D levels drop in winter alongside sunlight exposure, and plenty of people assume this is the mechanism behind SAD. The connection is plausible on the surface: vitamin D is produced in the skin in response to UV light, and lower levels have been associated with depression in observational research. But when tested directly for SAD, the results are underwhelming. A double-blind, placebo-controlled trial in healthcare workers found only a weak correlation between vitamin D levels and well-being, and no correlation at all between vitamin D levels and SAD symptom scores. Correcting a deficiency is worth doing for plenty of other health reasons, but viewing vitamin D as a treatment for seasonal depression is not well supported by the current evidence.

Summer SAD Exists Too

Most people picture SAD as a winter phenomenon, and it usually is. But a summer-pattern variant exists, and it looks quite different. A study from a tropical climate found that about 9% of respondents reported summer-level impairment consistent with SAD, while winter SAD affected only about 1.7%, a reversal of the pattern seen at higher latitudes. The meta-analysis cited earlier estimated summer-type SAD prevalence at well under 1% globally, making it far less common than the winter type.

Summer SAD’s symptoms differ from the winter pattern. Where winter SAD typically involves oversleeping, overeating, and weight gain, summer SAD tends toward insomnia, appetite loss, agitation, and sometimes anxiety. The mechanism is probably distinct as well. Heat and humidity rather than light deprivation seem to be driving factors. Light therapy, unsurprisingly, is not the treatment here. The existence of summer SAD is a reminder that seasonal depression is not simply about darkness, but about the brain’s sensitivity to environmental change in general.

An Evolutionary Relic

One hypothesis frames winter SAD as an exaggerated version of something that used to be useful. The typical symptom cluster of lethargy, increased sleep, social withdrawal, decreased sex drive, and increased appetite with weight gain looks remarkably like a mild form of hibernation. The idea is that for ancestral populations living at temperate latitudes, scaling back activity during winter and storing energy as fat would have improved survival. A mild mood uplift in spring and summer, which many people with SAD experience as slight hypomania, would then drive the reproductive activity timed to produce offspring when resources were abundant. This remains a hypothesis, not a proven explanation, but it does offer a coherent account of why the syndrome clusters the specific symptoms it does and why some degree of seasonal mood variation is nearly universal.

Children and Teenagers

SAD is not an adult-only condition, though it often looks different in younger people. In children, the dominant symptoms tend to be irritability, fatigue, and difficulty with schoolwork rather than the classic sadness adults report. A nationally representative survey of U.S. children and adolescents found that the seasonal effect on depressive symptoms was age-dependent. Parents of 16- to 18-year-olds rated depressive problems as significantly worse in fall and winter compared to spring and summer, but no such seasonal pattern appeared in children aged 6 to 15. The milder, subsyndromal form, sometimes called the “winter blues,” is more common than full SAD at any age. In teenagers, seasonal depression can easily be mistaken for ordinary adolescent moodiness or academic burnout, which means it often goes unrecognized and untreated during the years when it may first emerge.